On 2nd September 2004, Italy (Agencizia Italiana del Farmaco) presented to the EMEA a referral under Article 30 of Directive 2001/ 83/ EC, in order to harmonise the nationally authorised summaries of product characteristics, PL and labelling of the medicinal product Neurontin and associated names.